Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline
Lara E. Coelho(UCLA Medical Center), Beatriz Grinsztejn(Fundação Oswaldo Cruz), Raphael J. Landovitz(APLA Health), Valdiléa G. Veloso
Cited by 106
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|847